Literature DB >> 19691932

Genetic risk and protective factors for the idiopathic inflammatory myopathies.

Terrance P O'Hanlon1, Frederick W Miller.   

Abstract

The idiopathic inflammatory myopathies, or myositis syndromes, are heterogeneous autoimmune diseases defined by chronic muscle inflammation of unknown cause. They likely develop after the interaction of genetic and environmental risk factors in the absence of protective factors. The known genetic risk and protective factors are common alleles at polymorphic immune response loci and vary depending on phenotype. Furthermore, genetic associations are stronger with phenotypes defined by clinical features and autoantibodies than with myositis patients as a whole. Genetic factors for myositis also vary by age of onset, ethnicity, and environmental exposure group. Of interest, risk genes for one phenotype are often protective for another, possibly explaining the mutual exclusivity of many myositis subgroups. International collaborations using genome-wide association studies are needed to identify additional genes, gene-gene, and gene-environment interactions, all of which have pathogenic, therapeutic, and preventative implications for these increasingly recognized disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19691932     DOI: 10.1007/s11926-009-0040-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  44 in total

1.  Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies.

Authors:  A G Engel; K Arahata
Journal:  Hum Pathol       Date:  1986-07       Impact factor: 3.466

2.  Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK.

Authors:  Hector Chinoy; Fiona Salway; Sally John; Noreen Fertig; Brian D Tait; Chester V Oddis; William E R Ollier; Robert G Cooper
Journal:  Ann Rheum Dis       Date:  2007-04-03       Impact factor: 19.103

3.  Analysis of HLA-DM polymorphism in juvenile dermatomyositis (JDM) patients.

Authors:  J E West; A M Reed
Journal:  Hum Immunol       Date:  1999-03       Impact factor: 2.850

4.  Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians.

Authors:  Gulnara Mamyrova; Terrance P O'Hanlon; Jason B Monroe; Danielle Mercatante Carrick; James D Malley; Sharon Adams; Ann M Reed; Ejaz A Shamim; Laura James-Newton; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2006-12

5.  Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.

Authors:  Ejaz A Shamim; Lisa G Rider; Janardan P Pandey; Terrance P O'Hanlon; Luis J Jara; Eduardo A Samayoa; Ruben Burgos-Vargas; Janitzia Vazquez-Mellado; Jorge Alcocer-Varela; Mario Salazar-Paramo; Abraham Garcia Kutzbach; James D Malley; Ira N Targoff; Ignacio Garcia-De la Torre; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2002-07

6.  HLA-DRB1*15021 is the predominant allele in Japanese patients with juvenile dermatomyositis.

Authors:  Noriaki Tomono; Masaaki Mori; Shoko Nakajima; Takako Miyamae; Shuichi Ito; Toshihiro Mitsuda; Shumpei Yokota
Journal:  J Rheumatol       Date:  2004-09       Impact factor: 4.666

7.  Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies.

Authors:  Terrance P O'Hanlon; Lisa G Rider; Adam Schiffenbauer; Ira N Targoff; Karen Malley; Janardan P Pandey; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2008-10

8.  Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.

Authors:  Z E Betteridge; H Gunawardena; H Chinoy; J North; W E R Ollier; R G Cooper; N J McHugh
Journal:  Ann Rheum Dis       Date:  2008-10-17       Impact factor: 19.103

9.  Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies.

Authors:  H Chinoy; F Salway; S John; N Fertig; B D Tait; C V Oddis; W E R Ollier; R G Cooper
Journal:  Rheumatology (Oxford)       Date:  2007-06-22       Impact factor: 7.580

10.  Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.

Authors:  M Needham; I James; A Corbett; T Day; F Christiansen; B Phillips; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-02-07       Impact factor: 10.154

View more
  8 in total

1.  Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; Frederick W Miller
Journal:  JAMA       Date:  2011-01-12       Impact factor: 56.272

2.  Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

Authors:  Andrew L Mammen; Daniel Gaudet; Diane Brisson; Lisa Christopher-Stine; Thomas E Lloyd; Mary S Leffell; Andrea A Zachary
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-08       Impact factor: 4.794

Review 3.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

4.  The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.

Authors:  Adam Schiffenbauer; Sara Faghihi-Kashani; Terrence P O'Hanlon; Willy A Flegel; Sharon D Adams; Ira N Targoff; Chester V Oddis; Steven R Ytterberg; Rohit Aggarwal; Lisa Christopher-Stine; Ejaz A Shamim; Paul F Dellaripa; Sonye K Danoff; Andrew L Mammen; Frederick W Miller
Journal:  Semin Arthritis Rheum       Date:  2018-02-14       Impact factor: 5.532

5.  Postpartum Polymyositis Following Intrauterine Fetal Death.

Authors:  Manmohan P Borse; Tapas K Sahoo; Kumar V Anand; Manoj Kumar; Debasish Panda
Journal:  Indian J Crit Care Med       Date:  2020-08

6.  Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.

Authors:  David Wong; Bory Kea; Rob Pesich; Brandon W Higgs; Wei Zhu; Patrick Brown; Yihong Yao; David Fiorentino
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

Review 7.  Recent advances in the immunogenetics of idiopathic inflammatory myopathy.

Authors:  Hector Chinoy; Janine A Lamb; William E R Ollier; Robert G Cooper
Journal:  Arthritis Res Ther       Date:  2011-05-26       Impact factor: 5.156

8.  Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.

Authors:  F W Miller; W Chen; T P O'Hanlon; R G Cooper; J Vencovsky; L G Rider; K Danko; L R Wedderburn; I E Lundberg; L M Pachman; A M Reed; S R Ytterberg; L Padyukov; A Selva-O'Callaghan; T R Radstake; D A Isenberg; H Chinoy; W E R Ollier; P Scheet; B Peng; A Lee; J Byun; J A Lamb; P K Gregersen; C I Amos
Journal:  Genes Immun       Date:  2015-08-20       Impact factor: 2.676

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.